WA
ENZ

Whitebox Advisors’s Enzo Biochem, Inc. ENZ Stock Holding History

Whitebox Advisors’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-181,100
Closed -$753K – 441
2014
Q1 		$753K Buy
+181,100
New +$621K 0.03% 322

Other funds holding ENZ

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CPIM
Columbia Partners Investment Management Alexandria, Virginia $257M AUM 8.17% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return
CCM
Corsair Capital Management New York $673M AUM 109.99% 1-Year Est. Return

Whitebox Advisors's ENZ Position: Q2 2014 in Review

Whitebox Advisors sold out of Enzo Biochem, Inc. (ENZ) in Q2 2014, closing a stake of 181,100 shares — an estimated $753K sold.

Whitebox Advisors first reported a position in ENZ in Q1 2014 and held it in 1 quarter. The position peaked at $753K in Q1 2014. 86 funds tracked by Wall St. Rank hold ENZ as of Q2 2014.

  • Whitebox Advisors reported no remaining Enzo Biochem, Inc. position as of Q2 2014 after selling out during the quarter.
  • Whitebox Advisors sold 181,100 Enzo Biochem, Inc. shares in Q2 2014, an estimated $753K.
  • Whitebox Advisors first reported a position in Enzo Biochem, Inc. in Q1 2014 and held it in 1 quarter.
  • Whitebox Advisors's Enzo Biochem, Inc. position peaked at $753K in Q1 2014.
  • 86 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q2 2014.

Based on Whitebox Advisors's 13F filing for Q2 2014, filed 14 Aug 2014.